ClinicaSpace.com
Clinical Research
News & Careers
 
Search the Site
    
 
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   
 Top Breaking News
 Tuesday, September 02, 2014

Exelixis, Inc. (EXEL) Chops 70 Percent Of Workforce After Prostate Drug Cabozantinib Fails Pivotal Study

Novartis AG (NVS)'s New Heart Drug Cuts Cardiovascular Death Risk By 20 Percent; "Most Exciting Ever" Med Points To Huge Sales

Early Phase 3 Data Suggest Sanofi (France) (SAN.PA), Regeneron Pharmaceuticals, Inc. (REGN) Drug May Halve Heart Risk

Resverlogix Corporation (RVX.TO)'s RVX-208 Leads To A 77 Percent Relative Risk Reduction Of Major Heart Events

San Diego's ACADIA Pharmaceuticals, Inc. (ACAD) Wins FDA Breakthrough Therapy Designation For NUPLAZID™

Cipla Ltd. Takes A Bite Out Of GlaxoSmithKline (GSK)'s Profits As Copy Of Top Asthma Drug Lauches In Germany, Sweden

Amgen (AMGN) Submits Marketing Authorization Application For Cholesterol-Lowering Medication Evolocumab

Amgen (AMGN) Submits Marketing Authorization Application For Talimogene Laherparepvec

More News



 Yesterday's Most Popular News 
AstraZeneca PLC (AZN) Pops On Possibility Of Another Pfizer Inc. (PFE) Bid; Start Of New Cancer Trial

Hundreds Of Girls Struck With Mystery Illness; Possibly Linked To Merck & Co., Inc. (MRK)'s Gardasil

Short Men Make Better Boyfriends And Husbands, New York University Study

Certain Toothbrushes Hold 3,000 Times More Germs, University of Texas Health Science Center Researchers Reveal

Biocryst Pharmaceuticals (BCRX) Expected To Jump Into Ebola Race In A Few Weeks

Amgen (AMGN)'s Cholesterol Lowering Drug Succeeds In Phase 3 Trial

Marijuana Compound Could Stop Or Slow Down Alzheimer’s, University of South Florida Study

Angry Face May Make You Appear Stronger, University of California, Santa Barbara Study

Overconfident People Are More Likely To Be Overrated, University of Exeter Study

OncoMed Pharmaceuticals, Inc. (OMED) Says FDA Lifts Partial Hold On Cancer Drug Trials For Vantictumab


 
-

 Featured Stories
 

  Today's Top Jobs

 Featured Employer
About Genzyme Genzyme is committed to discovering and delivering transformative therapies for patients with rare and special unmet medical needs, providing hope where there was none before. Genzyme has pioneered the development and delivery of transformative therapies for over 30 years. Founded in 1981 in Boston, Massachusetts, Genzyme evolved from a tiny start-up with just a handful of employees to one of the world's leading biotech companies. Acquired by Sanofi in 2011, Genzyme now benefits from the reach and resources of one of the world’s largest pharmaceutical companies, with a shared commitment to improving the lives of patients. Genzyme has long been known for our expertise in the class of rare genetic diseases known as lysosomal storage disorders (LSDs). LSDs remain the heart of our company today, but we have also expanded – through both in-house development and strategic acquisitions and partnerships – to other disease areas such as thyroid cancer and multiple sclerosis. Learn more at www.jobsatgenzyme.com. Follow our jobs on Twitter www.twitter.com/genzymejobs. Follow us on LinkedIn http://www.linkedin.com/company/genzyme. About Sanofi Sanofi, a global and diversified healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients’ needs. Sanofi has core strengths in the field of healthcare with seven growth platforms: diabetes solutions, human vaccines, innovative drugs, rare diseases, consumer healthcare, emerging markets, and animal health. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).

Show me jobs for this employer

 Careers
 
More Career Tips